Bristol-Myers Squibb

Contact
b-ms.de
+4989-12142-0

Bristol-Myers Squibb GmbH & Co. KGaA

Sapporobogen 6-8
80809 München
Germany
+4989-12142-0
b-ms.de
Contact
Profile News
Contact

About Bristol-Myers Squibb

Our commitment is to research, develop and deliver innovative medicines that help patients overcome serious diseases.

Read more about Bristol-Myers Squibb
Facts about Bristol-Myers Squibb
  • Focus : Manufacturer
  • Industry : Pharma

News about Bristol-Myers Squibb

Bristol-Myers Squibb

27-Jul-2023 | business & finance

Immatics Announces $35 Million Equity Investment from Bristol Myers Squibb

Immatics N.V., a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer immunotherapies, announced ...

Read news
Bristol-Myers Squibb

11-May-2022 | business & finance

Evotec and Bristol Myers Squibb extend and expand strategic partnership in protein degradation

Deal potential of $ 5 bn

Read news
Bristol-Myers Squibb

08-Oct-2021 | business & finance

Evotec expands neuroscience collaboration with Bristol Myers Squibb to include novel cell type

Triggers US$ 9.0 m payment to Evotec

Read news
Bristol-Myers Squibb

27-Apr-2021 | business & finance

Bristol Myers Squibb exercises option to extend targeted protein degradation partnership with Evotec

Evotec SE announced that Bristol Myers Squibb has decided to exercise their option to extend its partnership with Evotec in the field of targeted protein ...

Read news
Bristol-Myers Squibb

05-Jan-2021 | business & finance

Evotec achieves milestone in its neurodegeneration collaboration with Bristol Myers Squibb

Evotec receive a US$ 6 m payment

Read news
Bristol-Myers Squibb

08-Jan-2020 | business & finance

Evotec and Bristol-Myers Squibb expand iPSC collaboration

Evotec SE announced that the Company received a US$ 6 m payment from Bristol-Myers Squibb Company following the decision to expand the collaboration to ...

Read news
Bristol-Myers Squibb

14-Sep-2017 | people

Bristol-Myers Squibb Names Karen Vousden to Board of Directors

Bristol-Myers Squibb Company announced that its Board of Directors has elected Karen Vousden, Ph.D., to the Board, effective January 1, 2018. Dr. Vousden ...

Read news
Bristol-Myers Squibb

11-Sep-2017 | business & finance

Bristol-Myers Squibb completes previously announced acquisition of IFM Therapeutics

Bristol-Myers Squibb Company announced that it has completed the previously announced planned acquisition of IFM Therapeutics. The transaction includes ...

Read news
Show more news about Bristol-Myers Squibb

Here you will find Bristol-Myers Squibb GmbH & Co. KGaA